RCS - Voyager Life Limited - Intention to float on the Aquis Stock Exchange

Aquis ExchangeAnnouncement

26/04/2021 08:05

RNS Number : 5094W
  
Voyager Life Limited
  
26 April 2021
  
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
This announcement is not a prospectus or admission document and not an offer of shares for sale in any jurisdiction, including in or into Australia, Canada, Japan, South Africa or the United States. 
Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of the information contained in an Aquis Stock Exchange Growth Market admission document in its final form (together with any supplementary admission document, if relevant, the "Admission Document"), including the risk factors set out therein, that may be published by Voyager Life Limited in connection with Admission (as defined below).
 
Voyager Life Limited
("Voyager" or the "Company")
 
Announcement of intention to float on the Aquis Stock Exchange Growth Market
 
 
Voyager, the health and wellness company established to supply high-quality Cannabidiol (CBD) and hemp seed oil products, announces the Company's intention to seek admission to trading on the Aquis Stock Exchange Growth Market (Access Segment) ("Admission"). Admission is expected to occur in Q2-2021.
 
In February 2021 the Company launched a crowdfunding campaign through Seedrs, raising £874,000. This month Voyager has raised a further £741,000 through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.
 
Voyager was incorporated in November 2020 as a health and wellness business focused on CBD and hemp seed oil products. The Company's directors believe that a significant opportunity exists in the CBD market due to the forecast growth and ongoing regulatory changes.
 
The Company has a growing range of CBD and hemp seed oil products including oils, gummies, bath products and skincare products, which are available online through its website www.voyagercbd.com and through over 20 third party websites.
 
Nick Tulloch, CEO of Voyager, said: "We believe this is a sector with significant growth potential and our focus has been on building our product range alongside a robust approach to assurance and compliance as strong foundations to build the brand and the business. The Voyager team has extensive industry experience and our oversubscribed crowdfunding along with the strong support in our more recent fundraising underlines the significant investor appetite for our approach.
 
"At the time of our crowdfunding campaign in February 2021, we were clear with investors that our aspirations were to take Voyager onto the public markets when the time was right. The progress made by the business, coupled with strong investor backing, has enabled us to realise these plans far more rapidly than we originally envisaged. We believe that Aquis provides an ideal platform for Voyager to continue to build its profile and provide our investors with liquidity whilst maintaining the Company's EIS-qualifying status."
 
ENDS
 
The contents of this announcement, which has been prepared by and is the sole responsibility of the Company, have been approved by Cairn Financial Advisers LLP solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000, as amended.
 
Enquiries
 




Voyager Life Limited


Tel: +44 (0) 1738 505 130
 




Nick Tulloch, CEO


nick@voyagerlife.uk




Cairn Financial Advisers LLP
(AQSE Corporate Advisers)


Tel: +44 (0) 20 7213 0880




Liam Murray/Ludovico Lazzaretti


 




Bixteth Partners (Capital Markets adviser)


Tel: +44 (0)7768 814 222




Guy Briselden


 




Charlotte Street Partners (Financial Communications and Investor Relations)


Tel: +44 (0)131 516 5310
 




Andrew Wilson


andrew@charlottestpartners.co.uk




David Gaffney


david.gaffney@charlottestpartners.co.uk




Tom Gillingham


tom.gillingham@charlottestpartners.co.uk




IMPORTANT NOTICES AND DISCLAIMER
The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.
This announcement (the "Announcement") and the information contained in it is not for publication, release, transmission, distribution or forwarding, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which publication, release or distribution would be unlawful. This Announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in the United Kingdom, the United States, Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.  This Announcement has not been approved by Aquis Exchange PLC or by any other securities exchange. 
The ordinary shares in the capital of the Company ("Ordinary Shares") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, pledged, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in or into the United States absent registration under the Securities Act, except pursuant to an exemption from the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.  Such Ordinary Shares have not been approved, disapproved or recommended by the U.S. Securities and Exchange Commission, any state securities commission in the United States or any other U.S. regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of any offering of Ordinary Shares. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United States, Australia, Canada, Japan or the Republic of South Africa or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, Japan or the Republic of South Africa. No public offering of Ordinary Shares is being made in the United Kingdom, the United States or elsewhere. 
Cairn Financial Advisers LLP ("Cairn"), which is authorised and regulated by the Financial Conduct Authority for the conduct of regulated activities in the United Kingdom, is acting as Corporate Adviser to the Company and no one else in connection with Admission and is not acting for and will not be responsible to any person other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission. 
 
Bixteth Partners Limited ("Bixteth"), an appointed representative of Messels Ltd which is authorised and regulated by the Financial Conduct Authority for the conduct of regulated activities in the United Kingdom, is acting as advisor to the Company and no one else in connection with Admission and is not acting for and will not be responsible to any person other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission. 
This Announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events. These statements, which sometimes use words such as "aim", "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions which may occur in the future, are beyond the Company's control and could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. Statements contained in this Announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this Announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained in it, nor does it intend to. As a result of these risks, uncertainties and assumptions, no-one should place undue reliance on these forward-looking statements as a prediction of actual results or otherwise.
This Announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Company. Any investment decision to subscribe for Ordinary Shares in the Company must be made solely on the basis of the Admission Document, if published.
This Announcement does not constitute a recommendation concerning any investor's options with respect to the Ordinary Shares. Any investor or prospective investor should conduct his, her or its own investigation, analysis and evaluation of the business and data described in the Admission Document if, as and when it is published by the Company. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. 
Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this Announcement.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NRABLGDSRBDDGBU